Daxor (DXR) Institutional Ownership $7.24 +0.01 (+0.14%) As of 02/21/2025 03:24 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Daxor (NASDAQ:DXR)CurrentInstitutional OwnershipPercentage1.34%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$132.59KNumber ofInstitutional Sellers(last 12 months)0 Get DXR Insider Trade Alerts Want to know when executives and insiders are buying or selling Daxor stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Daxor Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2025 Renaissance Technologies LLC27,821$214K0.0%+87.7%0.575% 11/12/2024 Keyes Stange & Wooten Wealth Management LLC14,612$126K0.1%+34.8%0.302% (Data available from 1/1/2016 forward) DXR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DXR shares? During the previous two years, the following institutional investors and hedge funds held shares of Daxor shares: Renaissance Technologies LLC ($214K), Keyes Stange & Wooten Wealth Management LLC ($126K).Learn more on DXR's institutional investors. What percentage of Daxor stock is owned by institutional investors? 1.34% of Daxor stock is owned by institutional investors. Learn more on DXR's institutional investor holdings. Which institutional investors have been buying Daxor stock? The following institutional investors have purchased Daxor stock in the last 24 months: Renaissance Technologies LLC ($13K), and Keyes Stange & Wooten Wealth Management LLC ($3.77K). How much institutional buying is happening at Daxor? Institutional investors have bought a total of 16,771 shares in the last 24 months. This purchase volume represents approximately $132.59K in transactions. Related Companies Neuronetics Major Shareholders LENSAR Major Shareholders electroCore Major Shareholders Pro-Dex Major Shareholders Edap Tms Major Shareholders FONAR Major Shareholders TELA Bio Major Shareholders Milestone Scientific Major Shareholders Sensus Healthcare Major Shareholders iCAD Major Shareholders This page (NASDAQ:DXR) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daxor Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Daxor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
